Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Tissue Antigens|August 25, 2000
A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 moleculesR M Luiten, N Demotte, J Tine, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1996
Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigenR M Luiten, G J Fleuren, S O Warnaar, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
Patients' perspective on current treatments and demand for novel treatments in vitiligoV S Narayan, S E Uitentuis, R M Luiten, et al.British Journal of Cancer|September 1, 1996
Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinomaR M Luiten, L R Coney, G J Fleuren, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 19, 2015
Cytokine profiles in interstitial fluid from chronic atopic dermatitis skinK Szegedi, R Lutter, P C Res, et al.The British Journal of Dermatology|April 14, 2017
Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparationsJ E Lommerts, A A Meesters, L Komen, et al.Immunogenetics|January 1, 1991
Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP moleculesH S de Koster, M J Kenter, J D'Amaro, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2020
Ultraviolet photography in vitiligo: image quality, validity and reliabilityS E Uitentuis, M N Heilmann, R M Verdaasdonk, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic reviewV S Narayan, L L C van den Bol, N van Geel, et al.Pageof 3